Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
AZoLifeSciences on MSN

Advanced Statistical Method Reduces Noise in Single-Cell RNA-Sequencing Data

The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...

Tempus AI stock rises after FDA clearance for RNA sequencing device

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...
Zacks.com on MSN

Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD

TEM secures FDA clearance for its xR IVD device, advancing RNA-based cancer research and precision medicine tools.

Tempus AI Shares Up After FDA Clearance for In Vitro Diagnostic Device

Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...
The Scientist

Cytosurge and Lexogen Announce First End-to-End Commercial Live-Cell Sequencing Workflow

Live-seq brings longitudinal, non-destructive cell sequencing to every lab, revealing new insights into cellular behavior ...
News-Medical.Net

Achieving higher biological resolution from soil samples

The table shows the representative samples and their associated read counts. AutoNormalization effectively normalized the ...

Computational method cuts through the noise to bring clarity to single-cell analysis

The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...
News-Medical.Net on MSN

Stem cell treatment could help millions of people with end-stage kidney disease

More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine ...

Patient stem cells may offer new hope for end-stage kidney disease treatment

More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine ...

'Primed and ready': How one fast-acting type of white blood cell fights off infection in infants

From the moment they're born, newborns—or, specifically, their immune systems—must learn to fight germs without harming their ...